Brandon G. Smaglo

Brandon G. Smaglo is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on pancreatic cancer, encompassing clinical oncology, molecular pathology, and surgical oncology. He specializes in developing novel immunotherapies, including personalized neoantigen vaccines, engineered exosomes delivering KRASG12D-specific siRNA, and autologous multiantigen-targeted T cell therapy. His recent work also addresses racial and ethnic disparities in pancreatic cancer survival and KRAS mutation distribution, as well as vagal neuromodulation for cancer-associated cachexia. He has published in Nature Medicine, Nature Communications, and Cell, and received a $75,000 award for his cachexia research.